Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-22-015799

President & CEO gave up 12,162 shares (to pay taxes)

  • President & CEO acquired 52,041 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
KAKKIS EMIL D President & CEO 2022-03-01 Shares withheld for taxes −12,162 $67.37 $819,354 582,185 D: show line 1 in the form
KAKKIS EMIL D President & CEO 2022-03-01 Grant or award +52,041 634,226 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
KAKKIS EMIL D President & CEO 2022-03-01 Grant or award · Stock Option (Right to Buy) +92,360 92,360 D: show line 3 in the form
Loading xslF345X03/doc4.xml…